OBJECTIVE: We evaluated the bladder cancer risk associated with coffee consumption in a case-control study in Spain and examined the gene-environment interactions for genetic variants of caffeine-metabolizing enzymes. METHODS: The analyses included 1,136 incident cases with urothelial carcinoma of the urinary bladder and 1,138 controls. Odds ratios (OR) and 95% confidence intervals (CI) were adjusted for area, age, gender, amount of cigarette smoking, and years since quitting among former smokers. RESULTS: The OR (95% CI) for ever consumed coffee was 1.25 (0.95-1.64). For consumers of 1, 2, 3, and 4 or more cups/day relative to never drinkers, OR were, respectively, 1.24 (0.92-1.66), 1.11 (95% CI 0.82-1.51), 1.57 (1.13-2.19), and 1.27 (0.88-1.81). Coffee consumption was higher in smokers compared to never smokers. The OR for drinking at least 4 cups/day was 1.13 (0.61-2.09) in current smokers, 1.57 (0.86-2.90) in former smokers, and 1.23 (0.55-2.76) in never smokers. Gene-coffee interactions evaluated in NAT2, CYP1A2, and CYP2E1-02 and CYP1A1 were not identified after adjusting for multiple testing. CONCLUSION: We observed a modest increased bladder cancer risk among coffee drinkers that may, in part, be explained by residual confounding by smoking. The findings from the gene-coffee interactions need replication in further studies.
OBJECTIVE: We evaluated the bladder cancer risk associated with coffee consumption in a case-control study in Spain and examined the gene-environment interactions for genetic variants of caffeine-metabolizing enzymes. METHODS: The analyses included 1,136 incident cases with urothelial carcinoma of the urinary bladder and 1,138 controls. Odds ratios (OR) and 95% confidence intervals (CI) were adjusted for area, age, gender, amount of cigarette smoking, and years since quitting among former smokers. RESULTS: The OR (95% CI) for ever consumed coffee was 1.25 (0.95-1.64). For consumers of 1, 2, 3, and 4 or more cups/day relative to never drinkers, OR were, respectively, 1.24 (0.92-1.66), 1.11 (95% CI 0.82-1.51), 1.57 (1.13-2.19), and 1.27 (0.88-1.81). Coffee consumption was higher in smokers compared to never smokers. The OR for drinking at least 4 cups/day was 1.13 (0.61-2.09) in current smokers, 1.57 (0.86-2.90) in former smokers, and 1.23 (0.55-2.76) in never smokers. Gene-coffee interactions evaluated in NAT2, CYP1A2, and CYP2E1-02 and CYP1A1 were not identified after adjusting for multiple testing. CONCLUSION: We observed a modest increased bladder cancer risk among coffee drinkers that may, in part, be explained by residual confounding by smoking. The findings from the gene-coffee interactions need replication in further studies.
Authors: W Tassaneeyakul; D J Birkett; M E McManus; W Tassaneeyakul; M E Veronese; T Andersson; R H Tukey; J O Miners Journal: Biochem Pharmacol Date: 1994-05-18 Impact factor: 5.858
Authors: M Sala; S Cordier; J Chang-Claude; F Donato; A Escolar-Pujolar; F Fernandez; C A González; E Greiser; K H Jöckel; E Lynge; A Mannetje; H Pohlabeln; S Porru; C Serra; A Tzonou; P Vineis; J Wahrendorf; P Boffetta; M Kogevina Journal: Cancer Causes Control Date: 2000-12 Impact factor: 2.506
Authors: Caroline F Thorn; Eleni Aklillu; Ellen M McDonagh; Teri E Klein; Russ B Altman Journal: Pharmacogenet Genomics Date: 2012-05 Impact factor: 2.089
Authors: Luis D Boada; Luis A Henríquez-Hernández; Patricio Navarro; Manuel Zumbado; Maira Almeida-González; María Camacho; Eva E Álvarez-León; Jorge A Valencia-Santana; Octavio P Luzardo Journal: Int J Occup Environ Health Date: 2014-10-08
Authors: Ariane Mbemi; Sunali Khanna; Sylvianne Njiki; Clement G Yedjou; Paul B Tchounwou Journal: Int J Environ Res Public Health Date: 2020-11-03 Impact factor: 3.390